Variant | Gene | Risk Allele | Score vda | Association Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||
---|---|---|---|---|---|---|---|---|---|---|
|
0.070 | GeneticVariation | BEFREE | These findings suggest that the pri-miR-34b/c rs4938723CC and TP53 Arg72-Pro polymorphisms may be associated with the risk of glioma. | 30319976 | 2018 |
||||
|
0.070 | GeneticVariation | BEFREE | In conclusion, our meta-analysis, based on the combined data from published papers before May 2013, reveals no evidence for significant association between p53 Arg72Pro polymorphism and glioma risk. | 24488625 | 2014 |
||||
|
0.070 | GeneticVariation | BEFREE | Thus, there is limited evidence for the association between the</span> TP53 Arg72Pro polymorphism and risk of glioma, and more studies are needed to provide a more comprehensive assessment of the association in Asians. | 24046089 | 2014 |
||||
|
0.070 | GeneticVariation | BEFREE | In stratified analyses by ethnicity, source of controls, and glioma subtypes, the p53 codon 72 Arg/Pro polymorphism did not alter the risk for glioma in population-based, hospital-based, astrocytoma, and oligodendroglioma studies among Caucasian. | 23860773 | 2013 |
||||
|
0.070 | GeneticVariation | BEFREE | Association of p53 Arg72Pro and MDM2 SNP309 polymorphisms with glioma. | 23096687 | 2012 |
||||
|
0.070 | GeneticVariation | BEFREE | In this first assessment of the role of TP53 Arg72Pro polymorphism in a large series of Portuguese glioma tumors, no association was observed with glioma susceptibility or overall survival, except for patients submitted to adjuvant therapy. | 18068527 | 2008 |
||||
|
0.070 | GeneticVariation | BEFREE | Our data suggest that TP53 Pro47Ser and Arg72Pro SNPs are not involved either in susceptibility to developing gliomas or in patient survival, at least in the Brazilian population. | 18393224 | 2008 |